In summary, our data suggest that NKX2.1 may function as a tumor suppressor in primary gastric carcinoma and that its reduced expression independently predicts an unsatisfactory prognosis in gastric carcinoma patients. The gene discussed is NKX2-1; the disease is gastric carcinoma.